Research Article
Serum HMGB1 Serves as a Novel Laboratory Indicator Reflecting Disease Activity and Treatment Response in Ankylosing Spondylitis Patients
Figure 2
Changes in HMGB1 level and disease severity indices during follow-up. The black lines represent above indexes of AS patients treated with anti-TNF-a biologics and the gray lines represent patients treated with SASP and NSAIDs, during follow-up period. indicates ; indicates .
(a) |
(b) |
(c) |
(d) |
(e) |
(f) |
(g) |